ARIAD to Present at the Jefferies 2013 Global Healthcare Conference

  ARIAD to Present at the Jefferies 2013 Global Healthcare Conference

Jefferies Global Healthcare Conference 2013

Business Wire

CAMBRIDGE, Mass. -- May 30, 2013

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Jefferies 2013 Global Healthcare Conference being held in New
York City. Timothy P. Clackson, Ph.D., president of research and development
and chief scientific officer, will provide an overview of the Company’s
business on Wednesday, June 5, 2013 at 10:00 a.m. (ET).

The ARIAD presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company's website at
http://www.ariad.com/investor. A replay of the presentation will also be
available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
Twitter (@ARIADPharm).

Contact:

ARIAD Pharmaceuticals, Inc.
For Investors
Kendra Adams, 617-503-7028
Kendra.adams@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com
 
Press spacebar to pause and continue. Press esc to stop.